Active Pharmaceutical Ingredients under development
The following products are under development by various of our principals and may be at differing stages of production and regulatory progress. Further details available on request for any items of interest in respect of your own development programme:
| Aformoterol Tartrate |
| Asenapine |
| Bosentan |
| Cinacalcet |
| Clevidipine |
| Dalfampridine |
| Darifenacin |
| Desloratadine |
| Desvenlafaxine |
| Dexketoprofen Trometamol |
| Dolasetron Mesylate |
| Eletriptan |
| Esomeprazole Magnesium |
| Ibandronate Sodium |
| Iloperadine |
| Lacosamide |
| Levomepromazine Maleate |
| Lurasidone |
| Mitiglinide |
| Monteluksat |
| Olanzapine Polymorph |
| Olmesartan Medoxomil |
| Olopatadine |
| Paliperidone |
| Pamidronate Acid/Disodium |
| Prasugrel |
| Pregabalin |
| Retigabine |
| Risedronate |
| Rizatriptan Benzoate |
| Rufinamide |
| Saxagliptin |
| Solifenacin |
| Tazarotene |
| Telmisartan |
| Varenicline |
| Vildagliptin |
| Voriconaxole |
| Ziprasidone |
| Zoledronic Acid |
| Zolmitriptan |